Claritin and Omniscan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Omniscan (gadodiamide). Common drug interactions include gait disturbance among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Omniscan. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.



On Jul, 19, 2026

27 people who take Claritin and Omniscan together, and have interactions are studied.

Claritin and Omniscan drug interactions.

What are the common drug interactions of Claritin and Omniscan, by gender? *:

female:

  1. Gait disturbance
  2. Oedema peripheral (superficial swelling)
  3. Pain
  4. Pain in extremity
  5. Skin disorder (skin disease)
  6. Skin fibrosis (fibrous tissue formation on skin)
  7. Skin induration (an abnormally hard spot or area on the skin)
  8. Pruritus (severe itching of the skin)
  9. Grip strength decreased
  10. Joint stiffness

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Pain
  3. Skin hypertrophy (skin cells enlarges)
  4. Skin tightness
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood pressure increased
  7. Breath sounds
  8. Cough
  9. Emotional distress
  10. Heart rate decreased

What are the common drug interactions of Claritin and Omniscan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pruritus (severe itching of the skin)
  2. Rash erythematous (redness of the skin)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Anxiety
  2. Depression
  3. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  4. Joint stiffness
  5. Mobility decreased (ability to move is reduced)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Scar
  9. Abdominal pain
  10. Abdominal pain upper

40-49:

  1. Oedema (fluid collection in tissue)
  2. Rash
  3. Scar
  4. Vein discolouration
  5. Burning sensation
  6. Gait disturbance
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Muscle contracture (a permanent shortening of a muscle)
  9. Oedema peripheral (superficial swelling)
  10. Pain in extremity

50-59:

  1. Pain
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Asthenia (weakness)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood pressure increased
  6. Breath sounds
  7. Cough
  8. Fatigue (feeling of tiredness)
  9. Heart rate decreased
  10. Heart rate increased

60+:

  1. Abdominal distension
  2. Ammonia increased
  3. Hallucination (an experience involving the perception of something not present)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Liver disorder (liver diseases)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Nausea (feeling of having an urge to vomit)
  9. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  10. Non-small cell lung cancer (type of epithelial lung cancer)

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Brain: 17 people, 62.96%
  2. Headache (pain in head): 8 people, 29.63%
  3. Haemorrhage Intracranial (bleeding within the skull): 8 people, 29.63%
  4. Weakness: 6 people, 22.22%
  5. Pain: 5 people, 18.52%
  6. Multiple Myeloma (cancer of the plasma cells): 5 people, 18.52%
  7. Back Pain: 5 people, 18.52%
  8. Renal Vein Thrombosis (blood clot in renal vein): 4 people, 14.81%
  9. Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 14.81%
  10. Intervertebral Disc Protrusion (spinal disc protrusion): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Omniscan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Claritin and Omniscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omniscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omniscan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and gadodiamide (the active ingredients of Claritin and Omniscan, respectively), and Claritin and Omniscan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: